Sonova (SONVY) Stock Price, News & Analysis

Company Overview

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

Key Stats

• Today's Range: $67.71 to $68.10
• 50-Day Range: $67.95 to $77.48
• 52-Week Range: $54.18 to $77.56
• Volume: 15,971 shs
• Average Volume: 16,093 shs
• Market Capitalization: $20.26 billion
• P/E Ratio: N/A
• Dividend Yield: 0.84%
• Price Target: N/A
• Consensus Rating: Reduce

Sonova Stock Analysis - MarketRank™

Sonova scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sonova.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 22.27%

Earnings Growth

Earnings for Sonova are expected to grow by 22.27% in the coming year, from $2.20 to $2.69 per share.

Price to Earnings Growth Ratio

Sonova has a PEG Ratio of 3.58. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Sonova has a P/B Ratio of 7.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the outstanding shares of Sonova have been sold short.

Short Interest Ratio / Days to Cover

Sonova has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sonova has recently increased by 225.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Sonova has a dividend yield of 0.84%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sonova does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Sonova will have a dividend payout ratio of 21.19% next year. This indicates that Sonova will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the outstanding shares of Sonova have been sold short.

Short Interest Ratio / Days to Cover

Sonova has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sonova has recently increased by 225.00%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.47

News Sentiment

Sonova has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sonova this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added Sonova to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sonova insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.01% of the stock of Sonova is held by insiders.

Percentage Held by Institutions

Only 0.01% of the stock of Sonova is held by institutions.

SONVY Stock Analysis - Frequently Asked Questions

How have SONVY shares performed this year?

Sonova's stock was trading at $65.3250 at the beginning of the year. Since then, SONVY stock has increased by 4.0% and is now trading at $67.9450.
View the best growth stocks for 2024 here.

How do I buy shares of Sonova?

Shares of SONVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 12/03/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SONVY
• CUSIP: N/A
• CIK: 1450681
• Web: www.sonova.com
• Phone: (158) 928-0101
• Fax: 41-58-928-2011
• Employees: 18,151
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 30.88
• P/E Growth: 3.58
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.63
• Current Ratio: 1.45
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $3.80 billion
• Price / Sales: 5.33
• Cash Flow: $3.06 per share
• Price / Cash Flow: 22.22
• Book Value: $9.44 per share
• Price / Book: 7.20

Miscellaneous

• Outstanding Shares: 298,130,000
• Free Float: 298,104,000
• Market Cap: $20.26 billion
• Optionable: Not Optionable
• Beta: 1.24